Today we’re presenting Trillion Dollar Shot, a new series that explores the business story behind the rise of Ozempic and other blockbuster drugs being used for weight loss. The first episode focuses on the Novo Nordisk scientist who invented the compound that paved the way for Ozempic. You can find every episode on The Journal’s show feed.
Trillion Dollar ... Show More
Oct 15
Fiber Maxxing and Poo Maxxing, with Dr. Trisha Pasricha
Have you been puzzled by your poos or felt down about your dumps?? You’re not alone! So many of us are struggling with gut issues, which is why fiber is having a major moment. But even though we’re secretly guzzling psyllium husk, tons of us are too embarrassed to talk about our ... Show More
59m 4s
Oct 1
Why We Never Forget Our Teen Years, with Dr. Lisa Damour
Our brains go completely WILD when we go through our teenage years. It’s a time where it feels like every disagreement with our parents turns into World War III, and every idea that could get us killed sounds like the most fun we could ever have. In this episode, we get into the ... Show More
58m 38s
Mar 2024
The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)
On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo No ... Show More
58m 12s
Feb 2024
The Big Business Behind Weight Loss Drugs
It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ... Show More
33m 54s
Apr 2023
Encore: Diet Wars | Dieting 3.0 | 5
First there was Weight Watchers, then there was Noom, and now there’s…Wegovy? Bloomberg health reporter Emma Court helps us understand the evolution of dieting programs and where they’re going next. Later, Matthew Schnier of New York Magazine and The Cut walks us through his arti ... Show More
39m 12s
<p>Ozempic is being hailed as “the end of the Obesity Epidemic.” This week, Mike and Aubrey dig through the sensational claims. But will they make it past the caveats?<br/><br/><b>Links:</b> </p><ul><li><a href='https://globalnews.ca/news/9793403/ozempic-canada-scientist-venomous ... Show More
